Bhavneesh Sharma
Contributor since: 2014
Company: Vasuda healthcare analytics
Latest Articles
Vital Therapies: An Attractive Opportunity For An Acquirer To Get The ELAD System For Almost Free
Recent IPO Gritstone Oncology: Neoantigen Targeted Personalized T Cell Therapy In Cancers
Clearside Biomedical: Buy Or Sell Before 2018 Catalysts
Spectrum Pharmaceuticals: Buy Or Sell Before September Data?
ADMA Biologics: Buy Or Sell Before Bivigam PDUFA?
Recent IPO Replimune: Oncolytic Viral Technology
Exelixis: Buy Or Sell On The Dip, Subscriber Query
Agenus: Buy Or Sell?
Magenta Therapeutics: Developing Novel Treatments In Hematopoietic Stem Cell Transplants
My Favorite Investment For The Coming Biotech Bull Market (Bhavneesh Sharma)
Ovid Therapeutics: Beaten-Down IPO With Upcoming 2018 Catalysts
Adverum Biotechnologies: Gene Therapy Company And Our New Buy
U.S. Biotech/Pharma Sector Daily Observations Letter: March 27, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: March 26, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: March 22, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: March 21, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: March 20, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: March 19, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: March 15, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: March 14, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: March 13, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: March 12, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: March 7, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: March 6, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: March 5, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: March 1, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: February 27, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: February 26, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: February 22, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: February 21, 2018
ARMO BioSciences: Analysis And Valuation Of Recent Immune-Oncology IPO
U.S. Biotech/Pharma Sector Daily Observations Letter: February 20, 2018